Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis is a research paper published in Pharmaceutics (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. NIH
Grant: R01-HL111118
U.S. NIH
Grant: R21-HL159562
U.S. NIH
Grant: R21-HL131016
National Institutes of Health
Grant: 5R01HL111118-04
Uniform field controlled magnetic cell targeting to stents
National Institutes of Health
Grant: 1R21HL159562-01
Multimeric prodrugs for pulmonary hypertension therapy
National Institutes of Health
Grant: 1R21HL131016-01A1
Integrated drug-in-cell therapy of in-stent restenosis
FWCI
0.87
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals